ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - imunitný séra a imunoglobulíny, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. pozri časti 4. 4 a 5.
gavreto
roche registration gmbh - pralsetinib - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
lunsumio
roche registration gmbh - mosunetuzumab - lymfóm, folikulárny - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologiká - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastické činidlá - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
polivy
roche registration gmbh - polatuzumab vedotin - lymfóm b-buniek - antineoplastické činidlá - polivy v kombinácii s bendamustine a rituximab je indikovaný na liečbu dospelých pacientov s relapsed/žiaruvzdorné plošných veľké b-buniek lymfóm (dlbcl), ktorí nie sú kandidátmi na hematopoetickú transplantácii kmeňových buniek. polivy in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (r-chp) is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma (dlbcl).
flexicam
dechra veterinary products a/s - meloxicam - proti zápalové a protireumatické produkty - dogs; cats - orálna suspenzia:psy zmiernenie zápalu a bolesti v akútne a chronické ochorenia pohybového aparátu. riešenie pre vstrekovanie:psy zmiernenie zápalu a bolesti v akútne a chronické ochorenia pohybového aparátu. zníženie pooperačnej bolesti a zápalu po ortopedickej a mäkkej tkanivovej chirurgii. kočky: zníženie pooperačnej bolesti po ovariohysterektómii a menšej chirurgii mäkkých tkanív.
ms-h vaccine
pharmsure veterinary products europe ltd - mycoplasma synoviae kmeň ms-h - immunologicals pre aves, Živé bakteriálne vakcíny - kura - pre aktívnej imunizácie budúcich chovateľov brojlerových kurčiat, budúcnosti vrstva chovateľ sliepok a budúcnosti vrstva kurčiat na zníženie vzduchu sac lézie a znížiť počet vajec s abnormálne shell vzniku spôsobené mycoplasma synoviae.
alopurinol glenmark 300 mg tablety
ipca, produtos farmaceuticos, unipessoal lda, portugalsko - alopurinol - 29 - antirheumatica, antiphlogistica, antiuratica
alopurinol glenmark 100 mg tablety
ipca, produtos farmaceuticos, unipessoal lda, portugalsko - alopurinol - 29 - antirheumatica, antiphlogistica, antiuratica